Publications by authors named "Monica Trigal"

The role played by a sustained angiogenesis in cancer and other diseases stimulates the interest in the search for new antiangiogenic drugs. In this manuscript, we provide evidence that 1,8- dihydroxy-9,10-anthraquinone (danthron), isolated from the fermentation broth of the marine fungus sp. (HL-114-33-R04), is a new inhibitor of angiogenesis.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Monica Trigal"

  • - Monica Trigal's recent research focuses on the discovery of novel antiangiogenic compounds, specifically targeting the role of angiogenesis in cancer and other diseases.
  • - Her study presents danthron, an anthraquinone derived from a marine fungus, as a promising new inhibitor of angiogenesis, showcasing its potential therapeutic applications.
  • - The findings highlight danthron's interesting antitumor and antioxidant properties, marking it as a significant candidate for further investigation in cancer treatment options.